Capricor, Inc. Receives FDA Approval
Jul 9, 2012July 9, 2012: CapriCor Inc. Announces FDA Approval To Initiate ALLSTAR Trial of Allogeneic Stem Cell Therapy In Patients Following Heart Attack.
July 9, 2012: CapriCor Inc. Announces FDA Approval To Initiate ALLSTAR Trial of Allogeneic Stem Cell Therapy In Patients Following Heart Attack.